MEGACE Side Effects

6981435-X | Blood Glucose Increased
on Jul 06, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with increased appetite and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Megace dosage: 40mg/ml Oral Suspension. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), OS CAL (View Os-cal Review and Os-cal Label ), ACIDOPHILUS (Form Capsule) (View Acidophilus Review and Acidophilus Label ), DITROPAN XL (View Ditropan Xl Review and Ditropan Xl Label ), COLACE (View Colace Review and Colace Label ), PAXIL (View Paxil Review and Paxil Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6981433-6 | Amenorrhoea
Patient was taking Megace (View Usage). Patient had the following side effects: amenorrhoea on May 12, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with weight decreased and. Megace dosage: .

6981422-1 | Abdominal Discomfort, Weight Increased
Adverse event was reported on Sep 14, 2009 by a Female patient taking Megace (View Usage) (Dosage: Megace Suspension 1 Teaspoon Daily) . Location: UNITED STATES , 81 years of age, After Megace was administered, patient had the following side effects: abdominal discomfort, weight increased.

6981083-1 | Thrombosis
on Oct 23, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with weight decreased and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis. Megace dosage: 625 Mg/5 Ml, Oral.


6908269-6 | Chest Pain, Deep Vein Thrombosis, Dyspnoea, Pain In Extremity, Pulmonary Embolism
on Jul 16, 2010 Female patient from CROATIA (local name: Hrvatska) , 70 years of age, was diagnosed with essential hypertension and was treated with Megace (View Usage). Patient had the following side effects: chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), dyspnoea, pain in extremity, pulmonary embolism (What is pulmonary embolism?). Megace dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LISINOPRIL (Tabs) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6749900-8 | Blood Chloride Decreased, Blood Glucose Increased, Blood Potassium Decreased, Blood Urea Increased, Decreased Appetite, Dehydration, Diarrhoea, Failure To Thrive, Haemoglobin Decreased
Patient was taking Megace (View Usage). After Megace was administered, patient had the following side effects: blood chloride decreased, blood glucose increased, blood potassium decreased, blood urea increased, decreased appetite, dehydration, diarrhoea, failure to thrive, haemoglobin decreased on May 24, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, was diagnosed with appetite disorder, prophylaxis of nausea and vomiting and. Megace dosage: 1 Df=40mg/ml. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), COREG (View Coreg Review and Coreg Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN D (1df=50000 Unit) (View Vitamin D Review and Vitamin D Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), ZOFRAN (View Zofran Review and Zofran Label ), PLAVIX (View Plavix Review and Plavix Label ).

6663467-4 | Ischaemic Stroke
Adverse event was reported on Mar 26, 2010 by a Female patient taking Megace (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 73 years of age, Patient experienced the following unwanted or unexpected effects: ischaemic stroke. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOXEN (Loxen Sr Caps) (View Loxen Review and Loxen Label ), PLAVIX (View Plavix Review and Plavix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), QUINAPRIL HCL (View Quinapril Hcl Review and Quinapril Hcl Label ).

6645764-1 | Venous Thrombosis Limb
on Mar 18, 2010 Female patient from UNITED STATES , 84 years of age, weighting 125.7 lb, was diagnosed with decreased appetite and was treated with Megace (View Usage). Patient had the following side effects: venous thrombosis limb. Megace dosage: 400mg Daily Po. Patient was hospitalized.

6510474-8 | Adrenal Neoplasm, Cardiomegaly, Choking, Epiglottic Oedema, Loss Of Consciousness, Pharyngeal Mass, Unresponsive To Stimuli, Wheezing
on Dec 21, 2009 Male patient from UNITED STATES , 85 years of age, weighting 154.3 lb, was diagnosed with decreased appetite, weight control (What is weight control?) and was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: adrenal neoplasm, cardiomegaly, choking (What is choking?), epiglottic oedema, loss of consciousness, pharyngeal mass, unresponsive to stimuli, wheezing. Megace dosage: 800 Mg Once Daily Po. During the same period patient was treated with ADVIL (View Advil Review and Advil Label ), ATIVAN (View Ativan Review and Ativan Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FLOMAX (View Flomax Review and Flomax Label ), VICODIN (View Vicodin Review and Vicodin Label ), AVODART (View Avodart Review and Avodart Label ).

6424011-X | Renal Failure Chronic, Urinary Tract Infection
Patient was taking Megace (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure chronic, urinary tract infection (What is urinary tract infection?) on Oct 28, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 83 years of age, . Megace dosage: . Patient was hospitalized.

6404508-9 | Chest Pain, Dyspnoea, Nausea, Oedema Peripheral, Pain In Extremity, Renal Failure, Thrombophlebitis, Thrombosis
Adverse event was reported on Oct 13, 2009 by a Female patient taking Megace (View Usage) (Dosage: ) was diagnosed with endometrial cancer and. Location: GERMANY , 79 years of age, weighting 207.2 lb, Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, nausea (What is nausea?), oedema peripheral, pain in extremity, renal failure, thrombophlebitis, thrombosis. During the same period patient was treated with CONCOR (View Concor Review and Concor Label ), LEXAURIN (View Lexaurin Review and Lexaurin Label ), RAWEL (View Rawel Review and Rawel Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), ZALDIAR (View Zaldiar Review and Zaldiar Label ), SANVAL (View Sanval Review and Sanval Label ). Patient was hospitalized and became disabled.

6399746-8 | Chest Pain, Dyspnoea, Nausea, Oedema Peripheral, Pain In Extremity, Renal Failure, Thrombophlebitis
on Oct 09, 2009 Female patient from SLOVENIA , 79 years of age, weighting 207.2 lb, was diagnosed with endometrial cancer and was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, nausea (What is nausea?), oedema peripheral, pain in extremity, renal failure, thrombophlebitis. Megace dosage: . During the same period patient was treated with CONCOR (View Concor Review and Concor Label ), LEXAURIN (View Lexaurin Review and Lexaurin Label ), RAWEL (View Rawel Review and Rawel Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), ZALDIAR (View Zaldiar Review and Zaldiar Label ), SANVAL (View Sanval Review and Sanval Label ). Patient was hospitalized and became disabled.

6393979-2 | Extrapyramidal Disorder
on Jul 14, 2009 Female patient from UNITED STATES , 78 years of age, weighting 138.9 lb, was diagnosed with weight increased and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder. Megace dosage: Megace Liquid. 1 Df = 1 Tsp.. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (1 Df = 1/2 Tab.) (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ).

6393978-0 | Blood Triglycerides Increased
Patient was taking Megace (View Usage). Patient had the following side effects: blood triglycerides increased on Jul 21, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with endometrial cancer and. Megace dosage: .

6393977-9 | Intracranial Venous Sinus Thrombosis
Adverse event was reported on Jun 04, 2009 by a Female patient taking Megace (View Usage) (Dosage: ) was diagnosed with decreased appetite, skin cancer (What is skin cancer?) and. Location: UNITED STATES , 62 years of age, After Megace was administered, patient had the following side effects: intracranial venous sinus thrombosis. During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), KEPPRA (View Keppra Review and Keppra Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), DIFLUCAN (2 Doses) (View Diflucan Review and Diflucan Label ).

6393974-3 | Paraesthesia
on Sep 26, 2008 Male patient from UNITED STATES , 18 years of age, weighting 112.4 lb, was diagnosed with increased appetite and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia. Megace dosage: Weaned Ovr A 3wk Period Frm 1-teaspoon Tid,to 1-teaspoon Bid,to 1-teaspoon Qd 1 D.f = 1-teaspoon. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ).

6359915-X | Weight Increased
on Jun 17, 2009 Female patient from UNITED STATES , 52 years of age, was diagnosed with haemorrhage and was treated with Megace (View Usage). Patient had the following side effects: weight increased. Megace dosage: .

6359912-4 | Abnormal Dreams, Dyspepsia, Hyperhidrosis
Patient was taking Megace (View Usage). After Megace was administered, patient had the following side effects: abnormal dreams, dyspepsia, hyperhidrosis on Mar 20, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with uterine disorder, depression (What is depression?), anxiety (What is anxiety?) and. Megace dosage: 1 Df = 1 Tab.2008-jan09:1df; Jan09:2 Df.. During the same period patient was treated with LEXAPRO (Nov08-jan09:10mg;jan09-24feb09:20mg;25feb-10mar:10mg;11mar:20mg.) (View Lexapro Review and Lexapro Label ), XANAX (View Xanax Review and Xanax Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PERCOCET (View Percocet Review and Percocet Label ), CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ).

6359910-0 | Deep Vein Thrombosis
Adverse event was reported on Feb 12, 2009 by a Female patient taking Megace (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?).

6359909-4 | Dyspnoea
on Feb 10, 2009 Male patient from UNITED STATES , 88 years of age, was diagnosed with prostate cancer (What is prostate cancer?), anaemia, renal failure chronic, atrial fibrillation (What is atrial fibrillation?) and was treated with Megace (View Usage). Patient had the following side effects: dyspnoea. Megace dosage: . During the same period patient was treated with THALOMID (Increased By 50 Mg Weekly To 200mg (qhs)) (View Thalomid Review and Thalomid Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), LORTAB (View Lortab Review and Lortab Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6356094-X | Gait Disturbance, Haematuria
on Sep 10, 2009 Male patient from FRANCE , 77 years of age, weighting 172.0 lb, was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: gait disturbance, haematuria. Megace dosage: Introduced 15 Days Ago.. During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ZOMETA (View Zometa Review and Zometa Label ), ZOLADEX (View Zoladex Review and Zoladex Label ).

6302816-3 | Gait Disturbance
Patient was taking Megace (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance on Aug 06, 2009 from FRANCE Additional patient health information: Male patient , 77 years of age, . Megace dosage: Introduced 15 Days Ago..

6283378-6 | Deep Vein Thrombosis
Adverse event was reported on Jul 21, 2009 by a Female patient taking Megace (View Usage) (Dosage: 400 Mg Bid Po) was diagnosed with increased appetite and. Location: UNITED STATES , 84 years of age, weighting 123.5 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Patient was hospitalized.

6253250-6 | Hepatic Enzyme Increased
on Jun 29, 2009 Female patient from UNITED STATES , 61 years of age, weighting 119.0 lb, was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: hepatic enzyme increased. Megace dosage: . During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), EXELON (View Exelon Review and Exelon Label ), NAMENDA (View Namenda Review and Namenda Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6208193-0 | Nausea, Pain
on May 26, 2009 Male patient from UNITED STATES , 83 years of age, weighting 149.9 lb, was diagnosed with weight decreased, prostate cancer (What is prostate cancer?) and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), pain (What is pain?). Megace dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), COLACE (View Colace Review and Colace Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

6115446-3 | Acute Prerenal Failure, Clostridial Infection, Hepatorenal Syndrome, Metabolic Acidosis, Oesophageal Varices Haemorrhage, Renal Failure Acute, Respiratory Alkalosis
Patient was taking Megace (View Usage). Patient had the following side effects: acute prerenal failure, clostridial infection, hepatorenal syndrome, metabolic acidosis, oesophageal varices haemorrhage, renal failure acute, respiratory alkalosis on Dec 16, 2008 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with hepatic neoplasm malignant and. Megace dosage: Unk. During the same period patient was treated with ZOFRAN (Unk) (View Zofran Review and Zofran Label ), COMPAZINE (Unk) (View Compazine Review and Compazine Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ), CAPECITABINE (850 Mg/m2 On Days 1-14 Of Each 21-day-cycle) (View Capecitabine Review and Capecitabine Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6021735-3 | Acute Prerenal Failure, Clostridial Infection, Hepatorenal Syndrome, Metabolic Acidosis, Oesophageal Varices Haemorrhage, Renal Failure Acute, Respiratory Alkalosis
Adverse event was reported on Dec 16, 2008 by a Male patient taking Megace (View Usage) (Dosage: Unk) was diagnosed with hepatic neoplasm malignant and. Location: UNITED STATES , 59 years of age, After Megace was administered, patient had the following side effects: acute prerenal failure, clostridial infection, hepatorenal syndrome, metabolic acidosis, oesophageal varices haemorrhage, renal failure acute, respiratory alkalosis. During the same period patient was treated with ZOFRAN (Unk) (View Zofran Review and Zofran Label ), COMPAZINE (Unk) (View Compazine Review and Compazine Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ), CAPECITABINE (850 Mg/m2 On Days 1-14 Of Each 21-day-cycle) (View Capecitabine Review and Capecitabine Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5921148-6 | Nausea
on Nov 30, 2007 Female patient from UNITED STATES , 48 years of age, was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Megace dosage: .

5906950-9 | Meningioma
on Oct 02, 2008 Female patient from UNITED STATES , 45 years of age, weighting 190.0 lb, was diagnosed with breast cancer (What is breast cancer?), menstrual disorder, prophylaxis and was treated with Megace (View Usage). Patient had the following side effects: meningioma. Megace dosage: 1-2 Pills 1-2 Times Per Day Po. Patient was hospitalized.

5887997-8 | Abdominal Pain, Oesophagitis, Upper Gastrointestinal Haemorrhage
Patient was taking Megace (View Usage). After Megace was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), oesophagitis, upper gastrointestinal haemorrhage on Sep 04, 2008 from UNITED STATES Additional patient health information: Female patient , 42 years of age, . Megace dosage: 5 Ml Qd. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), DILANTIN /00017402/ (View Dilantin /00017402/ Review and Dilantin /00017402/ Label ), DAILY VITAMINS (View Daily Vitamins Review and Daily Vitamins Label ). Patient was hospitalized.

5853563-3 | Deep Vein Thrombosis
Adverse event was reported on Aug 19, 2008 by a Male patient taking Megace (View Usage) (Dosage: Frequency 1x) was diagnosed with neoplasm malignant and. Location: POLAND , 83 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), LERIVON (View Lerivon Review and Lerivon Label ), PRESTARIUM (View Prestarium Review and Prestarium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KALIPOZ (View Kalipoz Review and Kalipoz Label ).

5675686-4 | Decreased Appetite, Dehydration
on Mar 17, 2008 Male patient from UNITED STATES , 72 years of age, weighting 154.1 lb, was diagnosed with carcinoid tumour and was treated with Megace (View Usage). Patient had the following side effects: decreased appetite, dehydration. Megace dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MULTI VIT (View Multi-vit Review and Multi-vit Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), NIACIN (View Niacin Review and Niacin Label ), RITALIN (View Ritalin Review and Ritalin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ).

5574292-X | Asthenia, Fall, Hepatic Encephalopathy, Orthostatic Hypotension, Pyrexia, Unresponsive To Stimuli, Vomiting
on Dec 26, 2007 Male patient from UNITED STATES , 73 years of age, weighting 191.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: asthenia, fall (What is fall?), hepatic encephalopathy, orthostatic hypotension, pyrexia, unresponsive to stimuli, vomiting. Megace dosage: 800 Mg Po Qd. During the same period patient was treated with ZEVALIN (View Zevalin Review and Zevalin Label ), VORICONAZOLE (200 Mg Po Bid) (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.

5489185-6 | Arthralgia, Joint Swelling
Patient was taking Megace (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling on Jun 25, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 134.5 lb, was diagnosed with cachexia and. Megace dosage: . During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), VFEND (View Vfend Review and Vfend Label ).

5489184-4 | Amenorrhoea, Arthralgia, Food Craving, Headache, Heart Rate Increased, Joint Stiffness
Adverse event was reported on Jun 05, 2007 by a Female patient taking Megace (View Usage) (Dosage: ) was diagnosed with weight increased and. Location: UNITED STATES , weighting 125.7 lb, Patient had the following side effects: amenorrhoea, arthralgia, food craving, headache (What is headache?), heart rate increased, joint stiffness.

5489181-9 | Thrombosis
on Feb 16, 2007 Female patient from UNITED STATES , 31 years of age, weighting 125.7 lb, was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: thrombosis. Megace dosage: .

5489178-9 | Hot Flush
on Oct 19, 2006 Female patient from UNITED STATES , 65 years of age, weighting 165.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: hot flush. Megace dosage: . During the same period patient was treated with EYE DROPS (View Eye Drops Review and Eye Drops Label ).

5489177-7 | Cardiac Failure Congestive
Patient was taking Megace (View Usage). Patient had the following side effects: cardiac failure congestive on Oct 09, 2006 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with decreased appetite and. Megace dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), STEROIDS (View Steroids Review and Steroids Label ). Patient was hospitalized.

5489176-5 | Depression, Dysarthria, Feeling Abnormal, Insomnia
Adverse event was reported on Oct 09, 2006 by a Male patient taking Megace (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 123.5 lb, After Megace was administered, patient had the following side effects: depression (What is depression?), dysarthria, feeling abnormal, insomnia.

5455329-5 | Malignant Neoplasm Progression
on Sep 11, 2006 Male patient from UNITED STATES , 84 years of age, was diagnosed with neoplasm malignant and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression. Megace dosage: .

5455328-3 | Dizziness
on Jul 18, 2006 Female patient from UNITED STATES , 51 years of age, was diagnosed with anorexia and was treated with Megace (View Usage). Patient had the following side effects: dizziness (What is dizziness?). Megace dosage: .

5444242-5 | Deep Vein Thrombosis, Nausea, Pulmonary Embolism
Patient was taking Megace (View Usage). After Megace was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?) on Sep 04, 2007 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 245.0 lb, was diagnosed with endometrial hyperplasia and. Megace dosage: 40mg Daily Po. Patient was hospitalized.

5409649-0 | Asthenia, Balance Disorder, Dizziness, Fatigue, Lethargy, Muscular Weakness, Urinary Incontinence
Adverse event was reported on Aug 07, 2007 by a Female patient taking Megace (View Usage) (Dosage: 3 Times A Day Po) was diagnosed with anorexia, weight decreased and. Location: UNITED STATES , 83 years of age, weighting 90.00 lb, Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, dizziness (What is dizziness?), fatigue, lethargy, muscular weakness, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), NAMENDA (View Namenda Review and Namenda Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

5409213-3 | Bronchitis, Mental Status Changes, Staphylococcal Infection
on Aug 07, 2007 Female patient from UNITED STATES , weighting 126.1 lb, was diagnosed with weight decreased and was treated with Megace (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), mental status changes, staphylococcal infection (What is staphylococcal infection?). Megace dosage: 200ml Daily Po. During the same period patient was treated with PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), TUSSIONEX (View Tussionex Review and Tussionex Label ), LORTAB ELIXER (View Lortab Elixer Review and Lortab Elixer Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

5388921-7 | Abdominal Pain Lower, Asthenia, Diarrhoea
on Jul 13, 2007 Female patient from UNITED STATES , weighting 129.6 lb, was diagnosed with weight decreased and was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: abdominal pain lower, asthenia, diarrhoea. Megace dosage: 20 Ml Daily Po. During the same period patient was treated with IRON (View Iron Review and Iron Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), IMODIUM (View Imodium Review and Imodium Label ), ZOFRAN (View Zofran Review and Zofran Label ), FLAGYL (View Flagyl Review and Flagyl Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

5385068-0 | Anaemia, Syncope
Patient was taking Megace (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, syncope on Jul 06, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 133.4 lb, . Megace dosage: 40mg/ml - 20ml Daily Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), DEMADEX (View Demadex Review and Demadex Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), AVANDIA (View Avandia Review and Avandia Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5314863-9 | Abdominal Pain, Adrenal Insufficiency, Anorexia, Asthenia, Asthma, Back Injury, Chest Pain, Dehydration, Diarrhoea
Adverse event was reported on Apr 10, 2007 by a Female patient taking Megace (View Usage) (Dosage: (oral), (1 Df Oral)) was diagnosed with increased appetite, irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , weighting 104.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal insufficiency, anorexia, asthenia, asthma (What is asthma?), back injury, chest pain (What is chest pain?), dehydration, diarrhoea. During the same period patient was treated with ZELNORM (View Zelnorm Review and Zelnorm Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ATIVAN (View Ativan Review and Ativan Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

5314453-8 | Abasia, Asthenia, Inadequate Analgesia, No Therapeutic Response, Pain, Pitting Oedema, Weight Increased
on May 01, 2007 Female patient from UNITED STATES , weighting 144.0 lb, was diagnosed with pancreatic carcinoma metastatic, weight decreased and was treated with Megace (View Usage). After Megace was administered, patient had the following side effects: abasia, asthenia, inadequate analgesia, no therapeutic response, pain (What is pain?), pitting oedema, weight increased. Megace dosage: 800 Mg Qday Po. During the same period patient was treated with NOVOLIN R (View Novolin R Review and Novolin R Label ), COMPAZINE (View Compazine Review and Compazine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), CATAPRES (View Catapres Review and Catapres Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), DEMADEX (View Demadex Review and Demadex Label ). Patient was hospitalized.

5305652-X | Abdominal Pain, Blood Albumin Decreased, Oedema Peripheral, Pain In Extremity, Pitting Oedema, Thrombosis, Urine Output Decreased
on Apr 23, 2007 Female patient from UNITED STATES , weighting 134.0 lb, was diagnosed with pancreatic carcinoma metastatic, weight decreased and was treated with Megace (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood albumin decreased, oedema peripheral, pain in extremity, pitting oedema, thrombosis, urine output decreased. Megace dosage: 800 Mg Qday Po. During the same period patient was treated with GEMZAR + TAXOTERE (View Gemzar + Taxotere Review and Gemzar + Taxotere Label ), PROCRIT (View Procrit Review and Procrit Label ), TARCEVA (View Tarceva Review and Tarceva Label ). Patient was hospitalized.

5305648-8 | Abdominal Distension, Ascites, Back Pain, Condition Aggravated, Decreased Appetite, Deep Vein Thrombosis, Fatigue, Fluid Overload, Oedema Peripheral
Patient was taking Megace (View Usage). Patient had the following side effects: abdominal distension, ascites, back pain (What is back pain?), condition aggravated, decreased appetite, deep vein thrombosis (What is deep vein thrombosis?), fatigue, fluid overload, oedema peripheral on Apr 23, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 122.0 lb, was diagnosed with pancreatic carcinoma metastatic, weight decreased and. Megace dosage: 800 Mg Qday Po. During the same period patient was treated with GEMZAR + TAXOTERE (View Gemzar + Taxotere Review and Gemzar + Taxotere Label ), PROCRIT (View Procrit Review and Procrit Label ), TARCEVA (View Tarceva Review and Tarceva Label ). Patient was hospitalized.